13.79

2.78% 0.465

Cartesian Therapeutics Inc (RNAC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$13.33

Offen:

$13.43

24-Stunden-Volumen:

37,537

Relative Volume:

0.54

Marktkapitalisierung:

$352.59M

Einnahmen:

$26.00M

Nettoeinkommen (Verlust:

$-219.71M

KGV:

-0.277

EPS:

-49.8

Netto-Cashflow:

$-51.37M

1W Leistung:

+13.69%

1M Leistung:

+28.28%

6M Leistung:

-31.47%

1J Leistung:

-21.67%

1-Tages-Spanne:

$13.43

$14.56

1-Wochen-Bereich:

$11.95

$14.56

52-Wochen-Spanne:

$8.46

$26.50

Cartesian Therapeutics Inc Stock (RNAC) Company Profile

Firmenname

Cartesian Therapeutics Inc

Sektor

Healthcare (1167)

Branche

Biotechnology (651)

Telefon

301-348-8698

Adresse

7495 NEW HORIZON WAY, FREDERICK

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

RNAC's Discussions on Twitter

Vergleichen Sie RNAC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RNAC Cartesian Therapeutics Inc	13.59	345.97M	26.00M	-219.71M	-51.37M	-49.80
VRTX Vertex Pharmaceuticals Inc	466.86	120.60B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	565.98	60.80B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	327.90	42.87B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	596.47	36.23B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	297.75	31.54B	3.81B	-644.79M	-669.77M	-6.24

Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-09	Eingeleitet	Wedbush	Outperform
2024-12-19	Eingeleitet	BTIG Research	Buy
2024-08-06	Eingeleitet	TD Cowen	Buy
2024-07-02	Herabstufung	Oppenheimer	Outperform → Perform
2024-06-04	Eingeleitet	Oppenheimer	Outperform
2024-05-24	Eingeleitet	Mizuho	Buy
2024-04-23	Bestätigt	H.C. Wainwright	Buy
2024-04-23	Eingeleitet	Leerink Partners	Outperform
2023-08-18	Herabstufung	SVB Securities	Outperform → Market Perform
2022-06-14	Bestätigt	Needham	Buy
2022-06-06	Eingeleitet	SVB Leerink	Outperform
2021-06-15	Eingeleitet	BTIG Research	Buy
2021-01-26	Hochstufung	Mizuho	Neutral → Buy
2020-10-01	Herabstufung	Mizuho	Buy → Neutral
2020-10-01	Herabstufung	William Blair	Outperform → Mkt Perform
2020-06-12	Herabstufung	Stifel	Buy → Hold
2020-04-28	Eingeleitet	H.C. Wainwright	Buy
2020-01-29	Eingeleitet	Cantor Fitzgerald	Overweight
2020-01-21	Eingeleitet	William Blair	Outperform
2018-06-27	Eingeleitet	Janney	Buy
2017-03-30	Bestätigt	UBS	Buy

Alle ansehen

Cartesian Therapeutics Inc Aktie (RNAC) Neueste Nachrichten

08:21 AM

Technical signs of recovery in Cartesian Therapeutics Inc.Short-Term Swing Opportunity Summary Sheet - Newser

08:21 AM

07:16 AM

Price action breakdown for Cartesian Therapeutics Inc.Buy and Hold Strategy for Capital Safety - Newser

07:16 AM

06:27 AM

How does Cartesian Therapeutics Inc. generate profit in a changing economySuperior portfolio returns - jammulinksnews.com

06:27 AM

05:31 AM

How to integrate Cartesian Therapeutics Inc. into portfolio analysis tools Swing Trade Picks with High Potential - Newser

05:31 AM

05:16 AM

How strong is Cartesian Therapeutics Inc. company’s balance sheetBeginner Investor Planner With High Returns - jammulinksnews.com

05:16 AM

04:24 AM

What are Cartesian Therapeutics Inc. company’s key revenue driversExceptional market positioning - jammulinksnews.com

04:24 AM

Jul 27, 2025

Is Cartesian Therapeutics Inc. stock overvalued or undervaluedAchieve consistent profits with proven methods - jammulinksnews.com

Jul 27, 2025

What is the risk reward ratio of investing in Cartesian Therapeutics Inc. stockInvest confidently with data-driven strategies - jammulinksnews.com

Jul 27, 2025

What makes Cartesian Therapeutics Inc. stock price move sharplyConsistent high-performance stocks - jammulinksnews.com

Jul 27, 2025

Why Cartesian Therapeutics Inc. stock attracts strong analyst attention200 Percent Watchlist - Newser

Jul 27, 2025

New Product Launches: Will They Boost Cartesian Therapeutics Inc. Stock in 2025Free Stock Market Real-Time Monitoring - Newser

Jul 27, 2025

How Interest Rate Changes Impact Cartesian Therapeutics Inc. Stock PerformanceControlled Risk High Reward Plan - Newser

Jul 27, 2025

How Cartesian Therapeutics Inc. stock performs during market volatilityFree AI-Driven Trading Strategies - Newser

Jul 27, 2025

Jul 26, 2025

What analysts say about Cartesian Therapeutics Inc. stockBreakout portfolio performance - jammulinksnews.com

Jul 26, 2025

Jul 25, 2025